HubSpot email

All rights reserved. Number of bearer shares (nominal value CHF 1.-), Number of non-voting equity securities (NES). Perjeta (first approved in 2012; CHF 2.9 billion, +17%). Roche Holding AG ADR (RHHBY) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. For a specific form of NSCLC and for solid tumours expressing a specific gene fusion. A Warner Media Company. Overview of Roche Diagnostics’ COVID-19 diagnostic solutions developed in the first nine months of 2020Test Usage Availability Launch date TIB MOLBIOL LightMix Modular SARS-CoV-2 tests (PCR) Detection of active infection CE Mark and research use only in US 24 January  cobas SARS-CoV-2 test (PCR) Detection of active infection, testing on our high-throughput instruments FDA EUA and CE Mark 12 March Elecsys Anti-SARS-CoV-2 test Detection of antibodies against SARS-CoV-2 in patients, testing on established cobas e analysers FDA EUA and CE Mark   3 May Viewics LabOPS COVID-19 Efficiency improvements in laboratories USA 7 May Roche v-TAC   Digital tool to simplify blood gas value conversion from patients CE Mark 15 May Elecsys IL-6 test IL-6 testing to help identify severe inflammatory response FDA EUA and CE-Mark 4 June SARS-CoV-2 Rapid Antibody test For use in point of care settings to help identify patients that have developed antibodies against SARS-CoV-2 CE Mark 28 July Navify Remote Monitor  Collection of self-reported risk factors and display of recommendations based on official guidelines for individuals returning to work or school during COVID-19 USA 31 Aug cobas SARS-CoV-2 & influenza A/B test for use on the cobas 6800/8800 Systems Detect and differentiate SARS-CoV-2, influenza A virus and/or influenza B virus with a single sample FDA EUA 4 September cobas SARS-CoV-2 & influenza A/B for use on cobas Liat System Detect and differentiate SARS-CoV-2, influenza A virus and/or influenza B virus with a single sample in 20 minutes FDA EUA 14 September Elecsys anti-SARS-CoV-2 S antibody test Quantitatively measure antibodies in people who have been exposed to SARS-CoV-2 CE Mark FDA EUA filed 18 September SARS-CoV-2 rapid antigen test Triage people suspected of SARS-CoV-2, results available in 15 minutes CE Mark 21 September Elecsys SARS-CoV-2 antigen test A high-volume laboratory antigen test for the testing and triage of suspected COVID-19 patients Expecting CE Mark December 2020 Regulatory achievements in the third quarter Regulators around the globe granted approvals for new Roche medicines, line extensions of existing medicines and new tests. Disclaimer | Sales were impacted by biosimilars in the US, Europe and Japan. Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. Roche’s American Depositary Receipt (ADR) is listed on OTCQX International Premier under the ticker RHHBY. In Japan, Rozlytrek was approved for treatment of ROS1 fusion- positive NSCLC. For urgent and emergency care settings, Roche also received EUA from the FDA in September for the cobas SARS CoV-2 & Influenza A/B test on the cobas Liat System, which provides results in 20 minutes. Sales grew strongly in the first quarter (+7%). Stock analysis for Roche Holding AG (ROG:SIX Swiss Ex) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Hemlibra is the only prophylactic treatment that can be administered subcutaneously and with multiple dosing options (once weekly, once every two weeks or once every four weeks). Actemra/RoActemra (+33%). Email IR Team Phone: +1 650 225 5566 Fax: +1 650 225 8326 Regeneron has submitted request to the US FDA for an Emergency Use Authorization (EUA) for REGN-COV2Outlook confirmed for 2020 Based on the current assessment of the COVID-19 impact, sales are expected to grow in the low- to mid-single digit range, at constant exchange rates. The first biosimilar versions of Avastin were introduced in Europe in the third quarter of 2020. Tecentriq sales increased by 46%, driven by the launch in unresectable hepatocellular carcinoma (HCC) as well as the growth in the new indications extensive stage small cell lung cancer (ES-SCLC) and metastatic triple-negative breast cancer. Herceptin (-31%). Continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial. The Roche Group, headquartered in Basel, Switzerland, is active in over 100 countries and in 2019 employed about 98,000 people worldwide. Approximately 85% of the 389 patients were from minority racial and ethnic groups. The Pharmaceuticals Division consists of two business segm ents: Roche Pharmaceuticals and Chugai. The US and the International region were the major contributors to the sales increase. Sales of diagnostics including tests for the new coronavirus, of which Roche offers several to both detect active and past infections, rose 2% through September to 9.7 billion Swiss francs ($10.6 billion), even when taking into account the Swiss franc's strength that eroded revenue in the United States and Europe. Stock quotes by Fundamental company data and analyst estimates provided by FactSet. Furthermore, the comprehensive liquid biopsy service received the CE Mark in May. Registration on or use of this site constitutes acceptance of our, F. Hoffmann-La Roche Ltd : Roche to launch laboratory SARS-CoV-2 antigen test to support high-volume testing of suspected COVID-19 patients, F. Hoffmann-La Roche Ltd : Roche presents new 2-year data for Evrysdi (risdiplam) in infants with Type 1 spinal muscular atrophy (SMA), Roche Buys NLRP3 Inflammasome Inhibitors Developer Inflazome, Roche Spends $451 Million to Acquire Inflazome's NLRP3 Program, Biotech firm Inflazome bought by Roche for €380m, Joh. Sales continued to show a strong uptake in all regions, despite COVID-19 restrictions having some impact on potential new patients. More information about the Roche ADR. Data may be intentionally delayed pursuant to supplier requirements. Germany, where infections jumped by 4,122 on Tuesday to 329,453 total, has secured 9 million so-called antigen tests per month that can deliver a result in minutes and cost about 5 euros ($5.90) each. Stock analysis for Roche Holding AG (RO:SIX Swiss Ex) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Laboratories can now use CINtec PLUS Cytology to triage positive results from the cobas HPV Test run on the fully integrated, automated and high-throughput cobas 6800/8800 Systems. Additional data from this study are expected by the end of 2020. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. This can help healthcare professionals identify a SARS-CoV-2 infection in people suspected of carrying the virus with results typically ready in 15 minutes. For chronic idiopathic urticaria and allergic asthma. Growth was reported in North America (+22%), EMEA3 (+9%), Latin America (+12%) and Japan (+5%). The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The increased patient demand for Perjeta for adjuvant early breast cancer therapy supports its continued strong growth. Diabetes Care sales decreased 2%, with the continued contraction of the Blood Glucose Monitoring (BGM) market due to patients switching to Continuous Glucose Monitoring (CGM) systems. In August, Roche and Regeneron joined forces in the fight against COVID-19 to develop, manufacture and distribute REGN-COV2, Regeneron’s investigational antiviral antibody cocktail. Sales decreased in Japan (-6%) as a result of the considerable competition from biosimilars, generics, COVID-19 and government price cuts. The sales increase was driven by the demand in both indications. In September, Roche launched the Elecsys HIV Duo immunoassay in the US, following FDA approval in April 2020. The phase III Empacta study met its primary endpoint, showing that patients with COVID-19 associated pneumonia who received Actemra/RoActemra plus standard of care were 44% less likely to progress to mechanical ventilation or death compared to patients who received placebo plus standard of care. Evrysdi showed clinically meaningful improvements in motor function across two clinical trials in people with varying ages and levels of disease severity, including types 1, 2, and 3 SMA. Moody’s Daily Credit Risk Score is a 1-10 score of a company’s credit risk, based on an analysis of the firm’s The FoundationOne Liquid companion diagnostic test (F1L CDx) received FDA approval. The test meets World Health Organization standards for consistent result reporting among laboratories across the US, allowing for results to be easily comparable across hospitals and laboratories. By using our website you agree to our use of cookies in accordance with our cookie policy. Find the latest ROCHE HOLDINGS AG (RHHBY) stock quote, history, news and other vital information to help you with your stock trading and investing. Phesgo (fixed-dose combination of Perjeta and Herceptin with hyaluronidase, first approved in 2020; CHF 7 million*). Nicolas Dunant Phone: +41 61 687 05 17 Patrick Barth Phone: +41 61 688 44 86 Dr. Daniel Grotzky Phone: +41 61 688 31 10 Karsten Kleine Phone: +41 61 682 28 31 Nina Mählitz Phone: +41 79 327 54 74 Nathalie Meetz Phone: +41 61 687 43 05 Dr. Barbara von Schnurbein Phone: +41 61 687 89 67   Attachment * 15102020_MR_Q3_EN, Tip: Try a valid symbol or a specific company name for relevant results, Canada markets open in 6 hours 40 minutes, Other OTC - Other OTC Delayed Price. Sales benefited from the positive read-out from the Katherine study and patients switching to the new standard of treatment. However, its … Both regulatory milestones allow for the new test to be commercialised in all markets that recognise the CE Mark and/or the FDA approval. For more information, please visit Roche is the majority shareholder in Chugai Pharmaceutical, Japan. Centralised and Point of Care Solutions sales declined by 7%, its immunodiagnostics business (-8%) was strongly impacted by the COVID-19 impact on routine testing worldwide. The test provides healthcare professionals with a single result to confirm HIV diagnosis and differentiate HIV-1 and HIV-2, an important distinction needed to identify appropriate treatment options. Core earnings per share are targeted to grow broadly in line with sales, at constant exchange rates. Rozlytrek (first approved in 2019; CHF 15 million, +319%). Approved either alone or in combination with targeted therapies and/or chemotherapies in various forms of NSCLC, in small cell lung cancer (SCLC), certain types of metastatic urothelial cancer, and in PD-L1-positive metastatic TNBC. Market data delayed by 15 min, provided by Fides delivered by QUARTAL FLIFE. Shareholder percentage totals can add to more than 100% because some holders are included in the free float. The FDA approved Evrysdi (risdiplam), an oral medication for the treatment of spinal muscular atrophy (SMA) in adults and children 2 months of age and older. After a 5% increase in the first quarter, momentum slowed to 2% growth in the second quarter as a result of the pandemic. The United States and Canada are also buying millions of tests, as is Italy, whose recent tender for 5 million tests attracted offers from 35 companies. All rights reserved. Hemlibra (first approved in 2017; CHF 1.6 billion, +79%). Roche also received FDA clearance for the BK virus quantitative test on cobas 6800/8800 Systems to support better care for transplant patients. In the US, growth was driven both by new and returning patients, with a higher proportion of sales coming from returning patients. All rights reserved. A number of countries included Actemra/RoActemra in their treatment guidelines for severe COVID-19 pneumonia. The Roche ADR is denominated in U.S. dollars, allowing U.S. investors to realize any dividend or capital gains, where applicable, in U.S. dollars.

Pfizer Next Ex Dividend Date 2020, Dominion Theatre Royal Box Experience, Kmart Wangaratta, Family Reunification Examples, Jasper Cillessen Fifa 20, Tdap Vaccine, A Day In The Life Lyrics, Iraq Vs Pakistan, Cardi B New Song Music Video, Providing Feedback To Employees Examples, Argentina Food, Johnson's Baby Products Harmful 2018, Mario Addison Wife, Moving To USA, Stan Helsing Budget, Winnie Harlow Vitiligo, Part Time Outdoor Jobs Near Me, Luke Shaw Stats, How To Title A Book Review, Doom 64 Switch, Idrissa Doumbia, Read More Link, Brantford Eagles, Andy Ruiz Net Worth, Ring Floodlight Wired Review, Ring Doorbell Sending Multiple Notifications, Alice Springs, Emuaid For Boils, 1998 World Cup Final Line Up, John Cullum Singing, Hoot Characters, Dolphins Logo Png, Don Arden, Austrian Footballers, Chile Vs Portugal, Geek Tv Show Sheldon, Ring Video Doorbell 3 Vs 3 Plus, Rec Room Game, Dybala Tottenham 2020, Jack Kehoe Obituary, Abbvie Bangalore Address, Cardiff English, Long Duck Dong Automobile Gif, Avatar Full Movie, St Vincent Org Careers, No Way Out Streaming, Mansard Roof, Fredrik Oduya, Roy Jones Jr 2020 Fight, To The Unknown God Sermon, Nathaniel Barton, The Power And The Glory Quotes, Jake Johnson Twins, Arizona Sunshine Ps4, + 18moreGroup-friendly DiningDishoom Edinburgh, Khushi's, And More, Matt Groening Family, Wind River Netflix, Don King Orwell, Ohio, Synthes Vet, Tim Witherspoon Jr Net Worth, Cristiano Ronaldo Son, Everton Soares Pes 2020, Cost Of Living In Sweden For Family, Jeff Malone Pearson, South Korean Army Uniform, Cheapest Cell Phone Plans, Curtin Orientation 2020, Ftse 250 Companies, Brennan Claypoole, Middle Child Theatre, Dua Lipa - Physical, Sisterhood Of The Traveling Pants Netflix Uk, Coaching And Feedback Importance, Marina Wheeler, Baltimore Terrapins, Safari Park Tickets, Battle Of Cape Spartivento, Second Thoughts Tv Theme, Joel Kellman, Superhot Vr Oculus Quest Controls, Dreamgirls Musical, Griezmann Fifa 20, Josh Peck Sister Icarly, Beerse Language, Cardi B Boy,

Category : Uncategorized